Breakthrough Technologies in Skin Science

DermTech International is an emerging biotechnology company specializing in the development and validation of molecular tests using specimens derived from the skin.  We have developed a proprietary, non-invasive technique for sampling the surface layers of the skin in order to generate individual genetic profiles for commercial applications in the clinical research and medical diagnostic fields.

Click here to see more about the DermTech presentation at the Society for Investigative Dermatology 68th Annual Meeting and an interview with Dr William Wachsman, lead author of a key study using DermTech's EGIR 'tape stripping' technology to identify melanoma.

Click here to learn more about our patented technology, Epidermal Genetic Information Retrieval (EGIR^TM), and its applications in the areas of dermatology, molecular diagnostics and theranostics.  

Latest News Click on the links below to get more information about our technology... DERMTECH ADDS AUSTRALIAN THOUGHT LEADER DR. SCOTT MENZIES, DIRECTOR OF THE SYDNEY MELANOMA DIAGNOSTIC CENTRE, TO COMPANY’S MELANOMA ADVISORY BOARD. DERMTECH NAMES HERBERT A. FRITSCHE, PH.D., CHIEF OF CLINICAL CHEMISTRY AT M.D. ANDERSON CANCER CENTER TO COMPANY’S SCIENTIFIC ADVISORY BOARD DERMTECH STUDY ON MELANOMA MOLECULAR DIAGNOSTIC TO BE PRESENTED AT AACR DERMTECH ADDS ALLAN C. HALPERN, MD, CHIEF OF DERMATOLOGY AT MEMORIAL SLOAN-KETTERING CANCER CENTER, TO COMPANY’S MELANOMA ADVISORY BOARD DermTech and Stiefel Laboratories, Inc. Begin Feasibility Study to Discover Genes Involved in Acne DermTech Is Issued U.S. Patent for the Early Detection, Staging and Monitoring of Melanoma DermTech Appoints BioStatistical Pioneer, John Quackenbush, Ph.D. as a Member of the Company's Scientific Advisory Board DERMTECH NAMES DANIEL P. KOLK, PH.D., AS VICE PRESIDENT, PRODUCT DEVELOPMENT Tape Test May Sort Cancer From Nevi DermTech Raises Initial Funding as Part of Current Investment Round DERMTECH AND UCSF COLLABORATE TO EXPLORE POTENTIAL OF COMPANY’S EGIR TECHNOLOGY TO DEVELOP NOVEL COMPOUNDS FOR ANTI-AGING AND ATOPIC DERMATITIS Melanoma Study Using DermTech’s Non-Invasive EGIR Technology Wins Top Clinical Research Poster Prize at the Annual Society for Investigative Dermatology Meeting Dr. William Wachsman on Prostate Cancer Study (Television Interview, June 2006) Getting Answers on Tape (Los Angeles Times, August 2005) DermTech's EGIR Designed to Identify Diseases Through Skin (BioWorld Today, August 2005)